0
     

Report Added
Report already added
Europe Radiofrequency-Based Devices Market 2021-2031 by Product (Generators, Electrodes, Applicators, Probes, Cannulas, Needles, Others), Application (Pain Management, Aesthetics, Oncology, Cardiology, Gynecology, Others), End User (Hospitals, ASCs, Specialty Clinics, Others), and Country: Trend Forecast and Growth Opportunity

Europe Radiofrequency-Based Devices Market 2021-2031 by Product (Generators, Electrodes, Applicators, Probes, Cannulas, Needles, Others), Application (Pain Management, Aesthetics, Oncology, Cardiology, Gynecology, Others), End User (Hospitals, ASCs, Specialty Clinics, Others), and Country: Trend Forecast and Growth Opportunity

Europe radiofrequency-based devices market was valued at $985.3 million in 2021 and will grow by 12.6% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, an increasing focus on enhancing physical appearance, a rising preference for minimally invasive and non-invasive procedures, and technological advancements supported by the rising R&D investment in healthcare domain.
Highlighted with 32 tables and 46 figures, this 110-page report “Europe Radiofrequency-Based Devices Market 2021-2031 by Product (Generators, Electrodes, Applicators, Probes, Cannulas, Needles, Others), Application (Pain Management, Aesthetics, Oncology, Cardiology, Gynecology, Others), End User (Hospitals, ASCs, Specialty Clinics, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe radiofrequency-based devices market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe radiofrequency-based devices market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Generators
•Electrodes
•Applicators
•Probes
•Cannulas
•Needles
•Other Products

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Pain Management
•Aesthetics
•Oncology
•Cardiology
•Gynecology
•Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Hospitals
•Ambulatory Surgical Centers (ASCs)
•Specialty Clinics
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Germany
•UK
•France
•Spain
•Italy
•Netherlands
•Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
ALMA Lasers (Sisram Medical Ltd.)
AngioDynamics, Inc.
AtriCure, Inc.
Avanos Medical, Inc.
Becton Dickinson and Company
Boston Scientific Corporation
Bramsys Industria e Comercio Ltda
BVM Medical Limited
Conmed Corporation
Cutera, Inc.
Cynosure
Diros Technology Inc.
Johnson & Johnson
Medtronic Plc
Merit Medical Systems, Inc.
Smith & Nephew plc
Stryker Corporation
Venus Concept, Inc.
YA-MAN Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy21
2.1.2 Impact of COVID-19 on the Market23
2.2 Major Growth Drivers25
2.3 Market Restraints and Challenges32
2.4 Emerging Opportunities and Market Trends35
2.5 Porter’s Fiver Forces Analysis39
3 Segmentation of Europe Market by Product43
3.1 Market Overview by Product43
3.2 Generators45
3.3 Electrodes46
3.4 Applicators47
3.5 Probes48
3.6 Cannulas49
3.7 Needles50
3.8 Other Products51
4 Segmentation of Europe Market by Application52
4.1 Market Overview by Application52
4.2 Pain Management54
4.3 Aesthetics55
4.4 Oncology56
4.5 Cardiology57
4.6 Gynecology58
4.7 Other Applications59
5 Segmentation of Europe Market by End User60
5.1 Market Overview by End User60
5.2 Hospitals62
5.3 Ambulatory Surgical Centers (ASCs)63
5.4 Specialty Clinics64
5.5 Other End Users65
6 European Market 2021-2031 by Country66
6.1 Overview of European Market66
6.2 Germany69
6.3 U.K.72
6.4 France74
6.5 Spain76
6.6 Italy78
6.7 Netherlands80
6.8 Rest of European Market82
7 Competitive Landscape84
7.1 Overview of Key Vendors84
7.2 New Product Launch, Partnership, Investment, and M&A88
7.3 Company Profiles89
Abbott Laboratories89
ALMA Lasers (Sisram Medical Ltd.)91
AngioDynamics, Inc.92
AtriCure, Inc.93
Avanos Medical, Inc.94
Becton Dickinson and Company95
Boston Scientific Corporation96
Bramsys Industria e Comercio Ltda97
BVM Medical Limited98
Conmed Corporation99
Cutera, Inc.100
Cynosure101
Diros Technology Inc.102
Johnson & Johnson103
Medtronic Plc104
Merit Medical Systems, Inc.105
Smith & Nephew plc106
Stryker Corporation107
Venus Concept, Inc.108
YA-MAN Ltd.109
RELATED REPORTS110List of Tables:

Table 1. Snapshot of Europe Radiofrequency-Based Devices Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203122
Table 3. Regulatory Organizations by Region28
Table 4. World Health Spending by Region, $ bn, 2013-202028
Table 5. Main Product Trends and Market Opportunities in Europe Radiofrequency-Based Devices Market35
Table 6. Europe Radiofrequency-Based Devices Market by Product, 2021-2031, $ mn43
Table 7. Europe Radiofrequency-Based Devices Market by Application, 2021-2031, $ mn52
Table 8. Europe Radiofrequency-Based Devices Market by End User, 2021-2031, $ mn60
Table 9. Europe Radiofrequency-Based Devices Market by Country, 2021-2031, $ mn68
Table 10. Germany Radiofrequency-Based Devices Market by Product, 2021-2031, $ mn71
Table 11. Germany Radiofrequency-Based Devices Market by Application, 2021-2031, $ mn71
Table 12. Germany Radiofrequency-Based Devices Market by End User, 2021-2031, $ mn71
Table 13. U.K. Radiofrequency-Based Devices Market by Product, 2021-2031, $ mn73
Table 14. U.K. Radiofrequency-Based Devices Market by Application, 2021-2031, $ mn73
Table 15. U.K. Radiofrequency-Based Devices Market by End User, 2021-2031, $ mn73
Table 16. France Radiofrequency-Based Devices Market by Product, 2021-2031, $ mn75
Table 17. France Radiofrequency-Based Devices Market by Application, 2021-2031, $ mn75
Table 18. France Radiofrequency-Based Devices Market by End User, 2021-2031, $ mn75
Table 19. Spain Radiofrequency-Based Devices Market by Product, 2021-2031, $ mn77
Table 20. Spain Radiofrequency-Based Devices Market by Application, 2021-2031, $ mn77
Table 21. Spain Radiofrequency-Based Devices Market by End User, 2021-2031, $ mn77
Table 22. Italy Radiofrequency-Based Devices Market by Product, 2021-2031, $ mn79
Table 23. Italy Radiofrequency-Based Devices Market by Application, 2021-2031, $ mn79
Table 24. Italy Radiofrequency-Based Devices Market by End User, 2021-2031, $ mn79
Table 25. Netherlands Radiofrequency-Based Devices Market by Product, 2021-2031, $ mn81
Table 26. Netherlands Radiofrequency-Based Devices Market by Application, 2021-2031, $ mn81
Table 27. Netherlands Radiofrequency-Based Devices Market by End User, 2021-2031, $ mn81
Table 28. Radiofrequency-Based Devices Market in Rest of Europe by Country, 2021-2031, $ mn83
Table 29. Product Offerings of Main Vendors86
Table 30. Abbott Laboratories: Company Snapshot89
Table 31. Abbott Laboratories: Business Segmentation90
Table 32. Abbott Laboratories: Product Portfolio90

Report Title: Europe Radiofrequency-Based Devices Market 2021-2031 by Product (Generators, Electrodes, Applicators, Probes, Cannulas, Needles, Others), Application (Pain Management, Aesthetics, Oncology, Cardiology, Gynecology, Others), End User (Hospitals, ASCs, Specialty Clinics, Others), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM